Our team is dedicated to scouting
investors from all around the world.
FinTech, Hardware, SaaS … we diversify our portfolio of
investors to give you the best chance to find startup investors.
Maryland, United States
IT (& TMT) • BioTech • Businesses Solutions • Hardware (& Manufacturing) • HealthTech (& Fitness) • Web Security (& Privacy) • Insurance (& InsurTech) • Medical Devices (& Hospital Services)
Growth Equity Investor - Focus on Emerging Technologies
Growth Equity Investor - Focus on Emerging Technologies
Maryland, U.S.A.
BioTech • FinTech (& Financials services) • Hardware (& Manufacturing) • A.I. (& Big Data) • Blockchain (& Cryptos) • Gaming (& eSports) • Consumer
Idris Mokhtarzada is a Co-Founder and serves as the Chief Technology Officer at Truebill. Prior to that he was the Co-Founder of Webs. Idris spent over a decade cofounding and growing Webs.com, leading to it's eventual acquisition by Vistaprint in 2011. He holds several patents around graphical user interfaces.
Bethesda Maryland - Annapolis Maryland - Washington D.C, U.S.A.
Other • BioTech • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness)
Perseus is a merchant bank and private equity fund management company headquartered in Washington, D.C., with an office in New York and an associated advisory firm in Munich. Perseus has invested in numerous growth equity, turnaround, and buyout transactions in the United States, Canada, and Western Europe. Perseus manages seven private equity funds and makes control equity investments in middle market companies that offer opportunities for value creation and enhancement. Since its inception in 1995, Perseus has made investments in more than 60 portfolio companies in a wide variety of industries in which Perseus and its principals have expertise, including energy, environmental, and engineering technologies; healthcare; and branded consumer products. Perseus has raised more than $1.6 billion in capital commitments. Perseus Partners VII, L.P., which was established in 2006, is a $602 million fund focused on control investments in middle market growth equity transactions principally in the energy, environmental, and engineering technology, healthcare, and branded consumer products sectors. This fund has been fully committed or reserved. Perseus also co-manages a $449 million fund that invests exclusively in life sciences companies. Growth equity and turnaround investing have been core investment focuses of Perseus since inception, supplemented by occasional opportunistic leveraged buyouts when supported by appropriate market conditions.
McLean Virginia - Vienna Virginia - San Mateo California - London - Richmond Virginia - Annapolis Maryland - St. Louis Missouri - Warrenton Virginia - Columbia South Carolina - Virginia - , U.K.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Hardware (& Manufacturing) • A.I. (& Big Data) • Medical Devices (& Hospital Services)
Angel Investor and Venture Fund Manager
Beverly Hills California - London - New York City (NY) - Chicago Illinois - Bethesda Maryland - Indianapolis Indiana - Annapolis Maryland - Bellevue Washington - Houston Texas - Washington D.C - Indiana - Virginia - Texas - Illinois, U.S.A. - U.K. - India
Software (Web Marketplace Saas..) • Other • IT (& TMT) • Media • Education • BioTech • Businesses Solutions • FinTech (& Financials services) • Hardware (& Manufacturing) • IoT (& Wearables) • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Cannabis • Logistics (& Distribution)
Perseus is a merchant bank and private equity fund management company headquartered in Washington, D.C., with an office in New York and an associated advisory firm in Munich. Perseus has invested in numerous growth equity, turnaround, and buyout transactions in the United States, Canada, and Western Europe. Perseus manages seven private equity funds and makes control equity investments in middle market companies that offer opportunities for value creation and enhancement. Since its inception in 1995, Perseus has made investments in more than 60 portfolio companies in a wide variety of industries in which Perseus and its principals have expertise, including energy, environmental, and engineering technologies; healthcare; and branded consumer products. Perseus has raised more than $1.6 billion in capital commitments. Perseus Partners VII, L.P., which was established in 2006, is a $602 million fund focused on control investments in middle market growth equity transactions principally in the energy, environmental, and engineering technology, healthcare, and branded consumer products sectors. This fund has been fully committed or reserved. Perseus also co-manages a $449 million fund that invests exclusively in life sciences companies. Growth equity and turnaround investing have been core investment focuses of Perseus since inception, supplemented by occasional opportunistic leveraged buyouts when supported by appropriate market conditions.
London - San Francisco California - Chevy Chase Maryland - Fairfax Virginia - Vancouver British Columbia Canada - Newport Beach California ; California - U.S.A., U.S.A.
Software (Web Marketplace Saas..) • PropTech • IT (& TMT) • Media • BioTech • Hardware (& Manufacturing) • Retail (& E-Commerce) • Sales (& Marketing) • HealthTech (& Fitness) • Web Security (& Privacy) • Medical Devices (& Hospital Services) • Aerospace (& Defense) • Productivity
#UK #tech #entrepreneur @EnsygniaLtd - Onescan allows your #customers to go from looking to buying in under 10 seconds (even brand new ones). No #NFC needed.
College Maryland - Maryland - - College Park Maryland - Annapolis Maryland - Washington - U.S.A., U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Businesses Solutions • Energy • Retail (& E-Commerce) • CleanTech • Mobile • Consumer • Oil & Gas (& Mining)
Elana Fine serves as Managing Director at Dingman Center Angels.
Lutherville - Timonium Maryland - Cambridge - Baltimore Maryland, U.K.
IT (& TMT) • BioTech • IoT (& Wearables)
Dr. Philip Goelet is a Co-Founder and serves as an Executive Chairman at Chalante. Philip has extensive experience as a scientist, entrepreneur and investor. His scientific career started at the Laboratory of Molecular Biology (LMB, Cambridge UK) under the supervision of Jon Karn in the laboratory of Sydney Brenner, where he sequenced tobacco mosaic virus as part of his PhD at the University of Cambridge. He then pursued postdoctoral research in neuroscience at Columbia University with Nobel Laureate Eric Kandel. Prior co-founding Chalante and Acidophil, Philip co-founded and managed Molecular Tool (Baltimore, MD: pioneering single nucleotide polymorphism analysis, acquired by Orchid Biosciences) and RiboTargets (Cambridge UK: therapeutics based upon targeting RNA, merged with Vernalis). In parallel to co-founding Acidophil with Sydney Brenner, Philip co-founded Red Abbey Venture Partners, a health care private equity fund with Frank Bonsal and Matt Zuga.
Baltimore Maryland - New York City (NY), U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech
David Rose is the Founder and serves as Chief Executive Officer & Chairman at Gust. David is an Inc. 500 CEO, serial entrepreneur and angel investor who has founded or funded over 120 pioneering companies. Described by BusinessWeek as a "world conquering entrepreneur", by Forbes magazine as "New York's Archangel", and by Red Herring magazine as "patriarch of Silicon Alley", his New York Times best-selling books on startup development and financing are Angel Investing: The Gust Guide to Making Money and Having Fun Investing in Startups (2014) and The Startup Checklist: 25 Steps to a Scalable, High-Growth Business (2016), both published by Wiley. Each has become the standard text in its field, with the world's leading angel groups providing the investment book to all of their new members, and 500 US universities adopting The Startup Checklist as the text for their entrepreneurship progra From his initial involvement with the first online communities in the 1970s, through founding one of the first personal computer training companies in the 1980s, one of the first wireless data information networks in the 1990s, and the first global angel investing platform in the 2000s, David has been at the forefront of innovation in business and technology. Outside of his work with Gust, he is Managing Director of Rose Tech Ventures; Founder and Chairman Emeritus of New York Angels; Co-founder and Managing Director of the AREA accelerator; and Founding Track Chair for Finance, Entrepreneurship and Economics at Singularity University, the Google/NASA-sponsored post-graduate program in exponential technologies. He has a BA from Yale, an MBA in Finance from Columbia and a D. Eng. (hc) from Stevens Institute of Technology.
Menlo Park - San Francisco Bay Area, U.S.A.
Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • Energy • Retail (& E-Commerce) • A.I. (& Big Data) • Web Security (& Privacy) • Cloud Services (& Infrastructure) • Consumer • Productivity
Own a Hedge Fund that is constantly looking for businesses that have great growth potential
Investment Banking for Tech companies in Enterprise and Consumer segments. A veteran in Enterprise, Mobile and Digital Media, Corporate Development VR, Voice Powered AI, Smart Devices, Mobile Advertising, Gaming, Artificial Intelligence, and IoT. Extensive deal-making with Mobile Carriers, Major Brands, Media Companies, Advertisers, Enterprise Sales, and Business Development, OEM's, Internet of Things (IoT) and Venture Capital. Entrepreneur, Angel Investor.
Bethesda Maryland - Washington D.C, U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • FinTech (& Financials services) • CleanTech • A.I. (& Big Data)
Capitol Partners is a private equity firm seeking to realize superior medium-term capital gains by investing in consolidating, fragmented industries. Along with the firm's sister fund, New Horizons Venture Capital (see profile), the group manages $200 million in assets. Capitol Partners focuses on technology, scale, and infrastructure-intensive investments in select segments of the healthcare, Internet, telecommunications, and energy industries. The firm provides equity capital to support financing needs such as: Recapitalizations, Management-led buy-outs, Liquidity for existing shareholders, Mergers and acquisitions, and Capital investments. Historically the firm has made acquisitions of up to $50 million, with equity investments of up to $20 million.
Washington District of Columbia - Annapolis Maryland - Chevy Chase Maryland, U.S.A.
Other • IT (& TMT) • Media • BioTech • Businesses Solutions • Hardware (& Manufacturing) • Energy • CleanTech • A.I. (& Big Data) • HealthTech (& Fitness) • Logistics (& Distribution)
Formed in 2011, Farragut Capital Partners is a privately-held investment management firm providing mezzanine debt and equity capital to finance leveraged and management buy-outs, generational transfers, growth capital financings (internal growth and acquisitions), and recapitalizations. Over the last 55+ years the firm's partners have deployed close to $1 billion across 90+ investments. The firm invests $2-$8 million total investment, with the ability to accommodate larger transactions through its network of strategic partners. The firm looks for profitable companies with established revenues of at least $10 million.
Maryland, U.S.A.
BioTech
Founder and CEO at Northpond Ventures
Michael Rubin is the Founder and serves as the Chief Executive Officer at Kynetic. He is a Co-Founder and serves as the Chairman at ShopRunner. He is a Founder & Chief Executive Officer at Radial. Kynetic is the newest chapter in Rubin's storied career as one of the country's most successful and respected entrepreneurs. The company launched on the heels of eBay's $2.4 billion acquisition of GSI Commerce, Inc. Over a 12-year period, Rubin and his team built GSI into a global network of e-commerce, multi-channel and digital marketing businesses servicing 150 of the top 500 Internet retailers. Fueled by a true passion for building consumer internet businesses, Rubin formed Kynetic which consists of three previously owned GSI companies: Fanatics, a leading online retailer of licensed sports merchandise
New York - Maryland, U.S.A.
Software (Web Marketplace Saas..) • BioTech • Businesses Solutions • FinTech (& Financials services) • CleanTech • HealthTech (& Fitness) • Web Security (& Privacy)
Managing Director and General Counsel at Emerald Development Managers
Stephen Case serves as Chairman and Chief Executive Officer, Revolution; Founder and Partner, Revolution Growth at Revolution. Steve Case is one of America's best-known and most accomplished entrepreneurs, and a pioneer in making the Internet part of everyday life. For the past 15 years, Steve's focus has been on starting and scaling Revolution, the Washington DC-based investment firm that now backs entrepreneurs at every stage of their development. Revolution Growth has invested nearly $1 billion in growth-stage companies including Sweetgreen, Tempus, Tala, DraftKings, and Clear. Revolution Ventures has backed more than two dozen venture-stage companies, including Framebridge, Policygenius, and Bloomscape. The Rise of the Rest Seed Fund has invested in more than 130 startups in over 70 U.S. cities, in partnership with many of America's most successful entrepreneurs and investors. Steve's entrepreneurial career began in 1985 when he co-founded America Online (AOL). Under Steve's leadership, AOL became the world's largest and most valuable Internet company, helping to drive the worldwide adoption of a medium that has transformed business and society. AOL was the first Internet company to go public, and the best performing stocks of the 1990s, delivering a 11,616% return to shareholders. At its peak, nearly half of Internet users in the United States used AOL. In 2000, Steve negotiated the largest merger in business history, bringing together AOL and Time Warner in a transaction that gave AOL shareholders a majority stake in the combined company. To facilitate the merger, Steve agreed to step down as CEO when the merger closed. Steve's passion for helping entrepreneurs remains his driving force. He was the founding chair of the Startup America Partnership-an effort launched at the White House in 2011 to accelerate high-growth entrepreneurship throughout the nation. Steve also was the founding co-chair of the National Advisory Council on Innovation & Entrepreneurship, and a member of President Obama's Council on Jobs and Competitiveness, where he chaired the subcommittee on entrepreneurship. Steve has been a leading voice in shaping government policy on issues related to entrepreneurship, working across the aisle to advance public policies that expand access to capital and talent. He was instrumental in passing the JOBS (Jumpstart Our Business Startups) Act and the Investing in Opportunities Act, and is active in advocating on behalf of immigration reform and legislation that supports and accelerates the emergence of startup ecosystems in rising cities. Steve also serves as the Chair of the Smithsonian Institution, the world's largest museum and research complex. In this role, Steve leads the Board of Regents' efforts to increase the Institution's reach, impact and relevance. Steve is also Chairman of the Case Foundation, which he established with his wife Jean in 1997. Together the Cases have invested in hundreds of organizations, initiatives and partnerships with a focus on leveraging the Internet and entrepreneurial approaches to strengthen the social sector. In 2010, Steve and Jean joined The Giving Pledge, and publicly reaffirmed their commitment to give away the majority of their wealth to philanthropic causes. Steve is also the author of the New York Times bestselling book, The Third Wave: An Entrepreneur's Vision of the Future. In it, Case recounted many of the lessons he learned from building businesses, and outlined the growing importance of place, policy and partnerships.
Maryland, U.S.A.
Software (Web Marketplace Saas..) • IT (& TMT) • BioTech • Energy • Material Science • Medical Devices (& Hospital Services) • Investment Management
As a Partner at Greenspring Associates, I lead the firm’s Healthcare and Portfolio Impact teams although I act as a generalist. The Healthcare team is focused on venture fund, direct, & secondary investments. The Portfolio Impact team helps with targeted relationships with Corporates interested in innovation, venture funds, talent acquisition, & unique IT & HC events. At Greenspring, we invest in three distinct categories: venture funds of all stages, early and growth-stage companies alongside our managers, and secondary opportunities. Each investment category informs the other, helping us capture powerful data, all while furthering our goal of building trusted relationships with venture managers and founders. Our funds incorporate one or more investment categories, each optimized for clients’ specific objectives.Founded in 2000 to focus solely on venture capital investments, Greenspring Associates believes that deep relationships built on mutual trust lead to better returns. Our mission is to serve as a value-added, lifecycle partner for fund managers and entrepreneurs on both a primary and secondary basis. With a comprehensive investment platform, data analytics capabilities, and dedicated Portfolio Impact program, we manage over $11 billion in committed capital across diversified, direct, secondary, and bespoke venture strategies for a diverse group of institutions and high net worth individuals.